Tuis4AB • ETR
add
AbbVie Common Stock
Vorige sluiting
€178,65
Dagwisseling
€174,25 - €177,70
Jaarwisseling
€147,60 - €207,00
Markkapitalisasie
360,31 mjd USD
Gemiddelde volume
450,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 16,62 mjd | 10,04% |
Bedryfskoste | 6,40 mjd | 7,04% |
Netto inkomste | 1,82 mjd | 8 354,55% |
Netto winsgrens | 10,93 | 7 386,67% |
Wins per aandeel | 2,71 | 25,46% |
EBITDA | 7,66 mjd | 9,20% |
Effektiewe belastingkoers | 31,97% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 5,26 mjd | -5,36% |
Totale bates | 133,96 mjd | -0,89% |
Totale aanspreeklikheid | 137,19 mjd | 4,09% |
Totale ekwiteit | -3,23 mjd | — |
Uitstaande aandele | 1,77 mjd | — |
Prys om te bespreek | -96,57 | — |
Opbrengs op bates | 10,58% | — |
Opbrengs op kapitaal | 21,56% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,82 mjd | 8 354,55% |
Kontant van bedrywe | 5,22 mjd | -25,96% |
Kontant van beleggings | -1,46 mjd | 21,93% |
Kontant van finansiering | -4,17 mjd | 39,28% |
Netto kontantverandering | -400,00 m | 76,92% |
Beskikbare kontantvloei | 4,97 mjd | -27,58% |
Meer oor
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000.
The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
Gestig
10 Apr. 2012
Webwerf
Werknemers
57 000
